|
| Publications [#140776] of John D Hamilton
Papers Published
- JD Hamilton, Hepatitis B virus vaccine. An analysis of its potential use in medical workers.,
JAMA : the journal of the American Medical Association, UNITED STATES, vol. 250 no. 16
(October, 1983),
pp. 2145-50, ISSN 0098-7484
(last updated on 2007/12/26)
Abstract:
At the Duke University Medical Center, Durham, NC, there are approximately ten recognized hepatitis B virus (HBV) infections per year in employees. The hospital's hepatitis control program costs $91,995 per year, including costs for workman's compensation, hyperimmune globulin, laboratory tests, lost revenue, liability, personnel, and medical treatment. A program to immunize high-risk medical center personnel and to accommodate residual HBV problems in nonimmunized employees would cost $206,304 in the first year. By seven years the cumulative costs of an immunization program would equal those without a program and at ten years would be cost saving ($746,742 with program v $919,950 without a program). Given certain assumptions, HBV vaccine is a cost-beneficial alternative for a major employee health hazard.
Keywords:
Cost-Benefit Analysis • Hepatitis B • Hepatitis B virus • Hospitals, University • Humans • North Carolina • Personnel, Hospital* • Vaccination • Viral Vaccines* • economics • immunology* • prevention & control*
|
